Message boards index | Help | Search messages | Sign in

+ UKCAB + Public area + News, events, announcments + ‘What is Value in Healthcare?’ ― a one-day event on Thursday, March 29th 2012

‘What is Value in Healthcare?’ ― a one-day event on Thursday, March 29th 2012

Pages: 1

UK CAB Moderator
Global Moderator
Posts: 826
‘What is Value in Healthcare?’ ― a one-day event on Thursday, March 29th 2012
Posted on: February 23 2012, 12:46 pm

‘What is Value in Healthcare?’ ― a one-day event on Thursday, March 29th 2012
To be held at the Royal Pharmaceutical Society, 1 Lambeth High Street, London, SE1 7JN
Dear Uk Cab
We are sending your organisation this personal invitation on behalf of Engage Health Alliance Europe.
We would be delighted if you could register to come along and join in the discussion on the subject of ‘What is Value in Healthcare?
To register for the event please click here :  or copy and paste this url into your browser. 
Why this meeting?
The UK government is striving to curb levels of national debt, and healthcare systems are even more vulnerable than usual to spending cuts.This meeting therefore hopes to consider a whole series of questions on the subject of value in healthcare, including:
·         If we have to choose what to spend money on in healthcare systems, can we identify where we find value in those systems?
·         Should parts of the healthcare system be cut back—or even axed?
·         Alternatively, should investments in healthcare be applied? If so, where?
·         How can healthcare be made more efficient, without comprising the health of patients?
·         And how can preventive medicine be encouraged, so that populations become healthier, and less likely to need expensive services from healthcare systems?

Surprisingly, little or no hard data exists across Europe’s fragmented and opaque healthcare systems to help policymakers gain answers to these questions—which are all centered around the subject of the values we hold in healthcare.
The only widely-recognised tool in the measurement of value in health is health technology assessment (HTA), as practiced by the National Institute for Health and Clinical Excellence (NICE). But the methods and processes of both HTA and NICE have been challenged by various categories of healthcare stakeholders. Policymakers at NICE hold contrasting views, for example, to doctors, patients and industry on what value society expects from healthcare systems. The stark truth is that no consensus exists about what we—the disparate healthcare stakeholders—want from healthcare systems.

Hence, this unique conference

On Thursday, March 29th 2012, Engage Health will be bringing influential healthcare stakeholders together at the Royal Pharmaceutical Society, London.
The aim is to gain an understanding of what society sees as value for modern-day national healthcare systems.
As part of the dialogue, Engage Health has invited speakers from outside the UK to provide insights about how their countries’ healthcare systems attempt to draw the greatest value out of the money spent on nationalised healthcare.
The meeting will look at HTA as a case study, and contemplate the problems of developing tools that hope to measure value within healthcare.
What will happen at the meeting?
The meeting’s programme includes presentations from patient groups, senior policymakers, commissioners, industry and providers. The meeting’s conclusions will be published as a WHITE PAPER, to stimulate further debate and action.
[The White Paper written after the Engage Health Alliance meeting in Brussels in November 2011, entitled ‘A Crisis in Healthcare—Closing the Stakeholder Gap’, will be publicly available on the Engage Health Alliance website from late February 2012 onwards, so that you can get an idea of what an Engage Health Alliance White Paper looks like, and hopes to achieve.]
Who is speaking?
Confirmed speakers currently include:
·         Josie Godfrey, Head of Policy and Co-ordination, National Specialised Commissioning Team, NHS.
·         Aidan Halligan, Director of Education, University College London Hospital [provisional].
·         Henry Purcell, Senior Fellow in Cardiology; Director, Cardiovascular Pathology of Obesity Research Group, Royal Brompton Hospital, London; and Editor-in-Chief, British Journal of Cardiology.
·         Katja Rupp, Manager, Deutsche Gesellschaft für Versicherte und Patienten e.V. (DGVP) [German Society for Insured Patients].
·         Karen Taylor, Director, Centre for Health Solutions, Deloitte UK.
·         Mark Wilkinson, Director, Life Sciences Innovation, NHS.
·         Andrew Wilson-Webb, Chief Executive, Rarer Cancers Foundation (RCF).
·         Alexandra Wyke, CEO, PatientView, will talk about the results of a study among 500 patient groups on the meaning of value in healthcare.

How you can be involved in the discussion:
With the help of a number of facilitators, participants at the meeting will be split into a number of cross-stakeholder groups.
Each of the groups will be challenged with the task of maintaining the UK NHS budget at its current level over the next five years—while improving both the life expectancy of people with chronic illness, and their quality of life.
In designing any health-reform packages, the meeting’s participants should assume the following:
·         The principle of universal healthcare (to be defined at the meeting) should continue to remain unchallenged.
·         But a greater emphasis should now be placed on primary care.
·         More attention, too, should be given to prevention and public health.
·         Greater transparency should be encouraged in healthcare—assisted by sensible investment in e-health.
·         Patients should be empowered more, so that they assume further responsibility for their care—yet without inflating demand on the healthcare system.
·         Regulations governing health professionals and medical research should be streamlined.

Participants’ health reforms may include changes to:
·         Both fixed and operational costs.
·         The methods of financing healthcare.
·         Health-technology assessment (HTA) processes.

At the end of the final session of the meeting, each cross-stakeholder group will report its findings to the conference.
TO REGISTER for attendance, please click here:
Engage Health Alliance Europe,
12 High Street, Stevenage, Hertfordshire, SG1 3EJ, UK
Tel: +44-(0)1438-870-066
Email: <> <>

Pages: 1

+ UKCAB + Public area + News, events, announcments + ‘What is Value in Healthcare?’ ― a one-day event on Thursday, March 29th 2012